Carnegie Capital Asset Management, LLC Pacific Biosciences Of California, Inc. Transaction History

Carnegie Capital Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$4.02 - $10.43 $111,643 - $289,661	-27,772 Reduced 66.09%	14,250 $63,000
Q2 2022 Jul 13, 2022	BUY	$4.02 - $10.43 $25,213 - $65,416	6,272 Added 17.54%	42,022 $1.47 Million
Q1 2022 Apr 11, 2022	SELL	$8.43 - $20.9 $41,492 - $102,869	-4,922 Reduced 12.1%	35,750 $325,000
Q4 2021 Jan 21, 2022	SELL	$19.26 - $30.08 $63,558 - $99,264	-3,300 Reduced 7.5%	40,672 $832,000
Q3 2021 Oct 08, 2021	BUY	$24.86 - $35.02 $48,477 - $68,289	1,950 Added 4.64%	43,972 $1.12 Million
Q2 2021 Jul 16, 2021	BUY	$22.3 - $36.02 $147,180 - $237,732	6,600 Added 18.63%	42,022 $1.47 Million
Q1 2021 Apr 12, 2021	BUY	$26.38 - $51.15 $161,498 - $313,140	6,122 Added 20.89%	35,422 $1.18 Million
Q4 2020 Feb 08, 2021	BUY	$10.5 - $28.5 $307,650 - $835,050	29,300 New	29,300 $760,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.